How to Tell the Difference Between Fibroids and Cancer: What to Know

Uterine fibroids are very common and benign. Uterine cancers, including endometrial cancer and the rarer uterine sarcomas, are much less common but require prompt diagnosis and specialist care. Because symptoms can overlap, it’s natural to wonder how doctors tell these conditions apart. This guide explains the differences, what warning signs to watch for, how testing works, and what to ask your clinician—drawing on guidance from trusted medical sources.

Fibroids 101: Common, Benign Growths

Fibroids (also called uterine leiomyomas) are noncancerous growths of muscle and connective tissue in the uterus. They are driven in part by hormones such as estrogen and progesterone and can vary in size from tiny seedlings to large masses that distort the uterus. Many people have no symptoms; others experience:

• Heavy or prolonged menstrual bleeding
• Pelvic pressure or pain
• Frequent urination or constipation (from pressure)
• Pain with sex
• Reproductive challenges in some cases

Fibroids are very common—by age 50, a large proportion of women will have them. They are especially prevalent among Black women and can appear at younger ages, grow larger, and cause more symptoms in some populations.

Uterine Cancer: Endometrial Cancer and Uterine Sarcoma

“Uterine cancer” usually refers to two main categories:

• Endometrial cancer arises from the uterine lining (endometrium). A hallmark symptom is postmenopausal bleeding, but it can also cause irregular or heavy bleeding before menopause.
• Uterine sarcomas (such as leiomyosarcoma) arise from the uterine muscle or connective tissue. They are rare but more aggressive than fibroids. They can cause bleeding, pelvic pain, or a rapidly enlarging mass, including after menopause.

Importantly, a Pap test does not screen for uterine (endometrial or sarcoma) cancers.

Why Symptoms Alone Usually Can’t Tell Them Apart

Fibroids and uterine cancers share overlapping symptoms—abnormal bleeding, pelvic pain, and pressure—so symptoms alone rarely provide a definitive answer. That’s why clinicians use a combination of history, exam, imaging, and, when indicated, tissue sampling. Even then, distinguishing a fibroid from a uterine sarcoma before surgery can be challenging; in many cases, a definitive diagnosis of sarcoma is made only after surgical removal and pathologic examination of the tissue.

Red Flags That Merit Prompt Evaluation

While most symptoms are caused by benign fibroids, the following warrant timely medical assessment:

• Postmenopausal bleeding (any bleeding after 12 months without periods)
• New or enlarging uterine mass after menopause
• Unexplained, persistent heavy bleeding leading to anemia
• Rapid uterine growth, especially after menopause
• Bleeding between periods or after sex

These signs do not prove cancer is present, but they do call for evaluation.

How Clinicians Distinguish Fibroids from Cancer

1) History and Physical Exam

Your clinician will review bleeding patterns, pain, pressure symptoms, reproductive goals, menopausal status, and risk factors (for example, obesity and unopposed estrogen increase endometrial cancer risk).

2) Imaging

• Transvaginal and transabdominal ultrasound are first-line. Fibroids often appear as well-defined, solid masses in or on the uterus. Ultrasound can also measure endometrial thickness in postmenopausal bleeding.
• MRI may be used when ultrasound is inconclusive or when pre-surgical planning is needed. MRI can highlight features suggestive of sarcoma (such as irregular borders, areas of necrosis, or very atypical signal), but imaging alone cannot fully rule in or rule out cancer.

3) Endometrial Sampling

For abnormal uterine bleeding—especially after age 45 or in anyone with risk factors—an endometrial biopsy is often performed to evaluate for endometrial cancer. A normal biopsy substantially reduces the likelihood of endometrial cancer as the cause of bleeding. However, a biopsy of the uterine lining may not detect a sarcoma if the tumor is within the muscle wall.

4) Hysteroscopy and Directed Sampling

When bleeding originates from the endometrial cavity (polyps, submucosal fibroids, or suspected endometrial cancer), hysteroscopy allows direct visualization and targeted biopsy.

5) Surgical Pathology (Definitive for Sarcoma)

A critical point: Leiomyosarcoma (a uterine sarcoma) often cannot be definitively diagnosed without surgical removal of the mass and microscopic evaluation. Preoperative needle biopsies of a fibroid-like mass may miss sarcoma due to sampling limitations.

Treatment Implications Differ

Fibroids: Management is individualized based on symptoms, size and location of fibroids, age, and fertility goals. Options include:

• Watchful waiting for small, asymptomatic fibroids
• Medications such as hormonal IUD (levonorgestrel), tranexamic acid for heavy bleeding, NSAIDs for pain, and short-term hormone-modulating therapies (for example, GnRH agonists or antagonists) to shrink fibroids or control bleeding
• Procedures including uterine artery embolization, myomectomy (surgical removal of fibroids), focused ultrasound or radiofrequency ablation, and hysterectomy (removal of the uterus) when appropriate

Uterine cancer: If cancer is suspected or confirmed, referral to a gynecologic oncologist is standard. Treatment often includes surgery (commonly hysterectomy, sometimes with lymph node assessment), and may include radiation, chemotherapy, or hormonal therapy depending on the cancer type and stage.

A Note on Power Morcellation

For selected patients with presumed fibroids, minimally invasive surgery can offer faster recovery. However, the U.S. Food and Drug Administration (FDA) has warned that power morcellation—a technique that fragments uterine tissue for removal—can spread unsuspected uterine sarcoma within the abdomen. The FDA recommends that if power morcellation is considered, it should be performed only with approved tissue containment systems and in appropriately selected patients after thorough informed consent. Discuss your personal risks and alternatives with your surgeon, especially if you are perimenopausal or postmenopausal, since risk of unsuspected sarcoma increases with age.

Practical Steps If You’re Concerned

• Track symptoms: Note bleeding patterns, pain, pressure, urinary or bowel changes, and any rapid growth.
• Seek evaluation for red flags: Particularly postmenopausal bleeding or new mass after menopause.
• Ask about appropriate testing: Ultrasound first; consider MRI for atypical features; endometrial biopsy for abnormal bleeding.
• Discuss goals: Fertility desires and preferences guide fibroid management choices.
• Get a second opinion if surgery is recommended, particularly for large or atypical masses.

Bottom Line

Most uterine masses are benign fibroids, but certain patterns—especially postmenopausal bleeding or rapid growth after menopause—warrant timely evaluation. Symptoms alone rarely distinguish fibroids from cancer; clinicians rely on imaging, endometrial sampling when indicated, and, in rare cases, surgical pathology to make a definitive diagnosis. If cancer is suspected, early referral to a gynecologic oncologist is key. Work closely with your clinician to choose a plan that matches your symptoms, risks, and goals.

This article provides general information and is not a substitute for medical advice. If you have worrisome symptoms, seek care promptly.

References (Trusted Sources)

• National Institute of Child Health and Human Development (NIH): Uterine Fibroids—Overview and Diagnosis. https://www.nichd.nih.gov/health/topics/uterine
• National Cancer Institute (NIH): Uterine Sarcoma Treatment (PDQ). https://www.cancer.gov/types/uterine/patient/uterine-sarcoma-treatment-pdq
• National Cancer Institute (NIH): Endometrial (Uterine) Cancer—Patient Version. https://www.cancer.gov/types/uterine
• U.S. Food and Drug Administration (FDA): Laparoscopic Power Morcellation—Safety Communications and Recommendations. https://www.fda.gov/medical-devices/surgery-devices/laparoscopic-power-morcellation-women
• American College of Obstetricians and Gynecologists (ACOG): Uterine Fibroids—FAQ. https://www.acog.org/womens-health/faqs/uterine-fibroids

---

---